---
document_datetime: 2024-12-05 15:12:50
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/posaconazole-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: posaconazole-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.5024416
conversion_datetime: 2025-12-25 00:01:04.913702
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Posaconazole Accord

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0017              | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation | 03/12/2024                          |                                             | SmPC and PL                      |           |
| II/0012/G            | This was an application for a group of variations.                                                                                                                                             | 18/04/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a manufacturer of the AS supported by an ASMF   |            |            |             |                                                                                                                                                                                                                                                                                 |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0014    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                  | 22/02/2024 | 09/04/2024 | SmPC        | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Posaconazole AHCL in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IA/0015   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                         | 17/01/2024 | n/a        |             |                                                                                                                                                                                                                                                                                 |
| IB/0013   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                             | 17/11/2023 | 07/12/2023 | SmPC and PL |                                                                                                                                                                                                                                                                                 |
| IA/0011   | A.6 - Administrative change - Change in ATC Code/ATC Vet Code                                                                                                                                                                                                                                            | 16/12/2022 | 29/11/2023 | SmPC        |                                                                                                                                                                                                                                                                                 |
| IB/0010/G | This was an application for a group of variations.                                                                                                                                                                                                                                                       | 25/04/2022 | 02/06/2022 | SmPC and PL |                                                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

|           | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                              |            |     |      |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|
| IB/0008/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an | 09/02/2022 | n/a | ASMF |

<div style=\"page-break-after: always\"></div>

|             | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                 | 31/01/2022   | 02/06/2022   | Annex II and PL                  | IA/0009              |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|----------------------|
| IAIN/0007   | C.I.3.a - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Implementation of wording agreed by the competent authority                                                                                    | 18/10/2021   | 02/06/2022   | SmPC and PL                      |                      |
| IB/0006/G   | This was an application for a group of variations. B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change process | 15/09/2021   | n/a          |                                  | in the manufacturing |
| IB/0005     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                  | 23/08/2021   | 04/10/2021   | SmPC, Annex II, Labelling and PL |                      |
| IB/0004     | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                     | 23/03/2021   | 04/10/2021   | SmPC                             |                      |
| IAIN/0003/G | This was an application for a group of variations. change - Deletion of                                                                                                                                                                                                                                                       | 09/10/2020   | 04/10/2021   | Annex II and PL                  | A.7 - Administrative |

<div style=\"page-break-after: always\"></div>

|           | sites B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing   |            |     | manufacturing   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------|
| II/0002   | B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a manufacturer of the AS supported by an ASMF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 08/10/2020 | n/a |                 |
| IB/0001/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for -replacement or addition of a site where                                                                                                                                                                | 28/11/2019 | n/a | the AS          |

<div style=\"page-break-after: always\"></div>

| batch control/testing takes place B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other   | variation   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|